RESULTS	At 3 months , total MENQOL score was significantly improved with BZA 20 mg/CE 0.625 mg and CE/MPA versus placebo ( P < 0.05 ) ; at 12 months , both BZA/CE doses and CE/MPA showed significant improvements ( P < 0.001 ) .\